Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
7.52
+0.08 (1.08%)
Feb 3, 2026, 3:04 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,4361,3881,4961,5501,3361,256
Other Revenue
13.6313.6315.4122.5821.4125.31
1,4491,4021,5121,5731,3581,281
Revenue Growth (YoY)
0.83%-7.25%-3.90%15.85%5.97%10.71%
Cost of Revenue
712.86719.73781.18847.06739.21695.09
Gross Profit
736.34682.36730.58726618.66586.27
Selling, General & Admin
391.6366.72346.78401.01352.64302.35
Research & Development
58.1861.7964.6286.9874.7652.05
Other Operating Expenses
24.517.4817.7722.3920.1719.71
Operating Expenses
476.13449.36431.89514.64462.16372.54
Operating Income
260.2233298.69211.36156.51213.73
Interest Expense
--1.34-2.57-6.79-12.94-19.65
Interest & Investment Income
36.8948.3823.8739.7114.1623.27
Currency Exchange Gain (Loss)
2.342.342.356.86-1.48-6.19
Other Non Operating Income (Expenses)
2.49-0.30.43-1.241.45-1.58
EBT Excluding Unusual Items
301.92282.09322.76249.9157.7209.58
Impairment of Goodwill
------5.56
Gain (Loss) on Sale of Investments
3.283.826.834.9931.44-3.52
Gain (Loss) on Sale of Assets
-0.17-0.2-0.09-0.06-0.583.36
Asset Writedown
-6.09-2.13-4.52-16.96-16.7-148.15
Other Unusual Items
12.219.754.7112.347.038.04
Pretax Income
311.16293.32329.7250.21178.8963.74
Income Tax Expense
44.6545.8553.2337.9238.9335.82
Earnings From Continuing Operations
266.51247.47276.47212.29139.9627.93
Minority Interest in Earnings
-41.72-34.81-28.77-0.0620.7483.07
Net Income
224.79212.65247.7212.23160.7110.99
Net Income to Common
224.79212.65247.7212.23160.7110.99
Net Income Growth
3.79%-14.15%16.71%32.06%44.79%-
Shares Outstanding (Basic)
819814814814814814
Shares Outstanding (Diluted)
819814814814814814
Shares Change (YoY)
0.62%-0.01%0.02%-0.00%-0.03%0.03%
EPS (Basic)
0.270.260.300.260.200.14
EPS (Diluted)
0.270.260.300.260.200.14
EPS Growth
3.15%-14.13%16.69%32.07%44.83%-
Free Cash Flow
334.83280.1262.93296.8225.02209.75
Free Cash Flow Per Share
0.410.340.320.360.280.26
Dividend Per Share
0.0790.0790.0920.0800.0600.041
Dividend Growth
-14.67%-14.67%15.00%33.33%46.34%-
Gross Margin
50.81%48.67%48.33%46.15%45.56%45.75%
Operating Margin
17.95%16.62%19.76%13.44%11.53%16.68%
Profit Margin
15.51%15.17%16.38%13.49%11.83%8.66%
Free Cash Flow Margin
23.11%19.98%17.39%18.87%16.57%16.37%
EBITDA
328.2307.95382.89319.43257.8297.72
EBITDA Margin
22.65%21.96%25.33%20.31%18.99%23.23%
D&A For EBITDA
67.9974.9484.21108.07101.2983.99
EBIT
260.2233298.69211.36156.51213.73
EBIT Margin
17.95%16.62%19.76%13.44%11.53%16.68%
Effective Tax Rate
14.35%15.63%16.14%15.16%21.76%56.19%
Revenue as Reported
1,4491,4021,5121,5731,3581,281
Advertising Expenses
-13.6913.657.2711.617.18
Source: S&P Global Market Intelligence. Standard template. Financial Sources.